Drug Type Small molecule drug, Other diagnostic agent |
Synonyms- |
Target |
Action agonists |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18ClNO3 |
InChIKeySWWQQSDRUYSMAR-UHFFFAOYSA-N |
CAS Registry11041-94-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Higenamine Hydrochloride | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Contrast agents | NDA/BLA | China | 24 Aug 2012 | |
| Contrast agents | NDA/BLA | China | 24 Aug 2012 | |
| Contrast agents | NDA/BLA | China | 24 Aug 2012 | |
| Coronary Disease | NDA/BLA | China | 24 Aug 2012 | |
| Coronary Disease | NDA/BLA | China | 24 Aug 2012 | |
| Coronary Disease | NDA/BLA | China | 24 Aug 2012 | |
| Coronary Disease | NDA/BLA | China | 24 Aug 2012 | |
| Angina Pectoris | Phase 3 | China | 10 May 2021 | |
| Angina Pectoris | Phase 3 | China | 10 May 2021 | |
| Angina Pectoris | Phase 3 | China | 10 May 2021 |





